Livagen

≥98% HPLCCOA per batchCold-chain shippedIn-house synthesisResearch use only · not for human consumption

Price range: $20.99 through $32.99

Independently verified Tested by IRZC Laboratories Batch NHV26-T5972 · Purity 99.12 % HPLC · Issued 4 Aug 2026 · Cert COA-W43E-X0RW-2Verify at IRZCVerifyScan to verify

A synthetic bioregulatory tetrapeptide designed to support liver function and chromatin decondensation for gene activation.

CASNot widely published
FormulaC18H31N5O9
Mol. weight461.47 g/mol
Chain4 residues
FormLyophilised powder
3 People watching this product now!
SKU: PEP-040 Category:

Molecular & analytical data

Verified chemistry and third-party reference identifiers for this compound.

Amino acid sequenceLys-Glu-Asp-Ala
Molecular formulaC18H31N5O9
Molecular weight461.47 g/mol
CAS numberNot widely published
PubChem CIDCID 87919683 ↗
Purity standard≥98%
Half-life~15-30 minutes (estimated for tetrapeptides)
BioavailabilityOral/Sublingual: active (short peptide bioregulator); Subcutaneous: high
Origin / sourceSynthetic; Khavinson bioregulator peptide family
Year discovered2000s
Livagen molecular structure
2D structure · source: PubChem

Reconstitution calculator

Concentration, volume per draw, and the graduation it measures to. Open the full bench calculator with this vial loaded →

Concentration— mg/mL— mcg per unit
—Draw tounits on a U-100 syringe
—Volume / drawmL
—Complete drawsper vial

—

A U-100 insulin syringe reads 100 units per 1 mL. Figures describe the contents of a vial for laboratory handling reference only and are not dosing guidance.

Quality & verification

Every batch is characterised before release and ships with documentation.

≥98%HPLC purity
461.47 g/molMolecular weight
MS + HPLCIdentity & purity assay
Third-party testedBatches are tested by IRZC Laboratories — independent HPLC + mass-spec confirms identity and purity against that product’s release specification.
Batch-matched COAA certificate of analysis is issued per batch and matched to your vial’s lot number.
Cold-chain fulfilmentLyophilised product is packed with insulated, temperature-controlled shipping.
Controlled synthesisProduced under documented, reproducible in-house processes with lot traceability.

Storage & handling

Keep the peptide stable from delivery through reconstitution.

1
On arrivalStore the sealed, lyophilised vial frozen at −20°C, protected from light and moisture.
2
ReconstitutionAdd bacteriostatic water down the vial wall; swirl gently — do not shake. Use the calculator above to plan volume.
3
After mixingRefrigerate the reconstituted solution at 2–8°C and use within the stability window below.
4
HandlingWork in a clean area, wipe the stopper with alcohol, and avoid repeated freeze–thaw cycles.
Manufacturer storage note

Lyophilized at -20°C. Capsules at room temperature.

Description

Livagen is a synthetic tetrapeptide (Lys-Glu-Asp-Ala) from the Khavinson bioregulator peptide family, designed to support hepatic (liver) function. Research suggests it can promote chromatin decondensation — the process of unwinding tightly packed DNA to allow gene expression — particularly in liver tissue. This mechanism may support hepatic regeneration and normalize liver function in aging or damaged tissue. It belongs to the growing class of short bioregulatory peptides that influence epigenetic regulation.

Certificates of Analysis

Certificates of Analysis

Every batch of this peptide is tested before release. Find the batch number printed on your vial and verify or download its certificate.

Batch #IssuedPurityCertificate
NHV26-T5972
COA-W43E-X0RW-2
04 Aug 202699.12 % HPLCVerify at IRZC ↗

“Verify at IRZC” opens the laboratory’s own record for that certificate, on their site. Looking for an older batch we haven’t published? Email [email protected] with the batch number from your vial — we keep all certificates for 7 years.

Research & Literature
Reported in research literature — not usage guidance.

The information below summarises published preclinical and clinical research for scientific reference. NHOV products are sold strictly for laboratory research use only. Nothing here is medical advice, a recommendation, or an instruction for use in humans or animals.

Mechanism of action

Promotes chromatin decondensation in hepatocytes, activates gene expression related to liver regeneration, supports hepatic function, bioregulatory effects on liver tissue.

Primary uses / indications

Liver support, hepatic regeneration research, epigenetic regulation studies, anti-aging

Typical dosage (reported)

10-20 mg daily orally. Injectable: 1-2 mg daily in research settings.

Cycle duration (reported)

10-20 days per course

Administration route

Oral (capsule), Subcutaneous injection

Side effects (reported)

Very limited data. Generally considered well-tolerated.

Contraindications

Pregnancy/breastfeeding, acute liver failure. Very limited safety data.

Drug interactions

Limited interaction data. Caution with hepatotoxic medications.

Reviews (0)
0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “Livagen”

Your email address will not be published. Required fields are marked *

You have to be logged in to be able to add photos to your review.

Specifications

Identity

Full name / brand namesLivagen (KEDA Peptide)
CategoryAnti-Aging & Longevity
SubcategoryBioregulatory Peptide
Origin / sourceSynthetic; Khavinson bioregulator peptide family
Year discovered2000s

Chemistry

Amino acid sequenceLys-Glu-Asp-Ala
Molecular formulaC18H31N5O9
Molecular weight461.47 g/mol
CAS numberNot widely published
PubChem CIDCID 87919683 ↗
Purity standard≥98%

Pharmacokinetics

Half-life~15-30 minutes (estimated for tetrapeptides)
BioavailabilityOral/Sublingual: active (short peptide bioregulator); Subcutaneous: high

Regulatory & research status

FDA statusNot FDA-approved. Research peptide.
Prescription requiredResearch use only
Research statusEarly research; limited published data. Part of Khavinson bioregulator program.
Clinical trialsNo registered clinical trials on ClinicalTrials.gov

References

Khavinson VK, "Peptides and Ageing", Neuroendocrinology Letters, 2002

Frequently asked questions

What is Livagen?
A synthetic bioregulatory tetrapeptide designed to support liver function and chromatin decondensation for gene activation.
How does Livagen work?
Reported in the research literature: Promotes chromatin decondensation in hepatocytes, activates gene expression related to liver regeneration, supports hepatic function, bioregulatory effects on liver tissue.
What Livagen dosage is used in research?
For laboratory research reference only, not usage guidance: 10-20 mg daily orally. Injectable: 1-2 mg daily in research settings.
What is the half-life of Livagen?
The reported biological half-life of Livagen is approximately ~15-30 minutes (estimated for tetrapeptides).
How should Livagen be stored and reconstituted?
NHOV ships Livagen as a lyophilised powder. Store unopened vials at −20 °C. Reconstitute with bacteriostatic water; once reconstituted, refrigerate at 2–8 °C, protect from light, and use within the bacteriostatic-water shelf window. Use the NHOV reconstitution calculator to find the exact volume for your target concentration.
What purity is NHOV's Livagen?
NHOV Livagen is released against a specification of ≥98%, verified by HPLC with mass-spectrometry identity confirmation, and ships with a batch-specific Certificate of Analysis (COA) matched to the vial's lot number.
Is Livagen approved for human use?
No. Livagen is sold strictly for laboratory and scientific research use only. It is not for human or veterinary consumption and is not approved as a drug.